• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.神经炎症以及与多巴胺能神经变性相关的α-突触核蛋白的氧化/硝化作用。
J Neurosci. 2008 Jul 23;28(30):7687-98. doi: 10.1523/JNEUROSCI.0143-07.2008.
2
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.神经炎症和α-突触核蛋白功能障碍相互促进,导致帕金森病小鼠模型中神经退行性变的慢性进展。
Environ Health Perspect. 2011 Jun;119(6):807-14. doi: 10.1289/ehp.1003013. Epub 2011 Jan 18.
3
Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.Cx3cr1 缺陷加剧了 α-突触核蛋白 A53T 诱导的帕金森病小鼠模型中的神经炎症和神经退行性变。
Glia. 2018 Aug;66(8):1752-1762. doi: 10.1002/glia.23338. Epub 2018 Apr 6.
4
Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.帕金森病 A30P/A53T 双突变α-突触核蛋白基因敲入小鼠模型中的年龄依赖性神经退行性变和神经炎症。
Neurobiol Dis. 2022 Sep;171:105798. doi: 10.1016/j.nbd.2022.105798. Epub 2022 Jun 21.
5
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.基于大鼠慢病毒的帕金森病模型中的α-突触核蛋白病与选择性多巴胺能神经元丢失
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16.
6
The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease.脂多糖(LPS)与 A53T-α-突触核蛋白的协同作用研究:鼻腔内 LPS 暴露对帕金森病 A53T-α-突触核蛋白转基因小鼠模型的影响。
Mol Neurobiol. 2024 Sep;61(9):7046-7065. doi: 10.1007/s12035-024-04020-y. Epub 2024 Feb 17.
7
Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.靶向 II 类转录激活因子可减轻帕金森病 α-突触核蛋白模型中的炎症和神经退行性变。
J Neuroinflammation. 2018 Aug 30;15(1):244. doi: 10.1186/s12974-018-1286-2.
8
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.抑制JAK/STAT信号通路可预防α-突触核蛋白诱导的神经炎症和多巴胺能神经退行性变。
J Neurosci. 2016 May 4;36(18):5144-59. doi: 10.1523/JNEUROSCI.4658-15.2016.
9
rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.rAAV2/7 载体介导的小鼠黑质中 alpha-突触核蛋白的过表达诱导蛋白聚集和进行性剂量依赖性神经退行性变。
Mol Neurodegener. 2013 Nov 25;8:44. doi: 10.1186/1750-1326-8-44.
10
The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration.戊糖磷酸途径调节慢性神经炎症和多巴胺能神经元退行性变。
J Neuroinflammation. 2019 Dec 5;16(1):255. doi: 10.1186/s12974-019-1659-1.

引用本文的文献

1
The role of T cells in the treatment of Parkinson's disease.T细胞在帕金森病治疗中的作用。
PeerJ. 2025 Aug 14;13:e19818. doi: 10.7717/peerj.19818. eCollection 2025.
2
Lipid metabolism in microglia: Emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (Review).小胶质细胞中的脂质代谢:神经退行性疾病的新机制与治疗机遇(综述)
Int J Mol Med. 2025 Sep;56(3). doi: 10.3892/ijmm.2025.5580. Epub 2025 Jul 11.
3
Caloric Restriction Mimetics as Priming Agents of Mesenchymal Stem Cells Secretome to Enhance Regenerative Responses to Parkinson's Disease.热量限制模拟物作为间充质干细胞分泌组的启动剂,以增强对帕金森病的再生反应。
Molecules. 2025 May 22;30(11):2260. doi: 10.3390/molecules30112260.
4
Exploring [11C]CPPC as a CSF1R-targeted PET imaging marker for early Parkinson's disease severity.探索[11C]CPPC作为早期帕金森病严重程度的CSF1R靶向正电子发射断层显像(PET)成像标记物。
J Clin Invest. 2025 Apr 15. doi: 10.1172/JCI186591.
5
Innate and adaptive immunity in neurodegenerative disease.神经退行性疾病中的先天性免疫和适应性免疫。
Cell Mol Life Sci. 2025 Feb 2;82(1):68. doi: 10.1007/s00018-024-05533-4.
6
α-Synuclein pathology as a target in neurodegenerative diseases.α-突触核蛋白病变作为神经退行性疾病的一个靶点。
Nat Rev Neurol. 2025 Jan;21(1):32-47. doi: 10.1038/s41582-024-01043-w. Epub 2024 Nov 28.
7
SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms.SARS-CoV-2 感染与α-突触核蛋白病:潜在关联及潜在机制。
Int J Mol Sci. 2024 Nov 10;25(22):12079. doi: 10.3390/ijms252212079.
8
Mapping the future of oxidative RNA damage in neurodegeneration: Rethinking the status quo with new tools.绘制神经退行性变中氧化 RNA 损伤的未来图谱:用新工具重新思考现状。
Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2317860121. doi: 10.1073/pnas.2317860121. Epub 2024 Nov 4.
9
The Interplay of Carveol and All-Trans Retinoic Acid (ATRA) in Experimental Parkinson's Disease: Role of Inflammasome-Mediated Pyroptosis and Nrf2.香芹酚与全反式维甲酸(ATRA)在实验性帕金森病中的相互作用:炎性小体介导的细胞焦亡和Nrf2的作用
Neurochem Res. 2024 Nov;49(11):3118-3130. doi: 10.1007/s11064-024-04226-5. Epub 2024 Aug 27.
10
Posttranslational Modifications of -Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases.- 突触核蛋白的翻译后修饰、它们的治疗潜力,以及在健康和神经退行性疾病中的相互作用。
Pharmacol Rev. 2024 Oct 16;76(6):1254-1290. doi: 10.1124/pharmrev.123.001111.

本文引用的文献

1
Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation.活化小胶质细胞释放谷氨酸需要氧化爆发和脂质过氧化。
J Neurochem. 2007 Jun;101(5):1205-13. doi: 10.1111/j.1471-4159.2007.04487.x. Epub 2007 Mar 30.
2
Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model.在A53T转基因小鼠模型中,接触农药会加剧α-突触核蛋白病。
Am J Pathol. 2007 Feb;170(2):658-66. doi: 10.2353/ajpath.2007.060359.
3
Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease.离子通道阻断可减弱小胶质细胞活性氧由聚集的α-突触核蛋白诱导产生:对帕金森病发病机制的意义。
J Neurochem. 2007 Jan;100(2):503-19. doi: 10.1111/j.1471-4159.2006.04315.x.
4
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?猴子和人类中与年龄相关的α-突触核蛋白增加与黑质纹状体多巴胺耗竭有关:这是帕金森病的靶点吗?
Neurobiol Dis. 2007 Jan;25(1):134-49. doi: 10.1016/j.nbd.2006.08.021. Epub 2006 Oct 18.
5
The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease.G蛋白偶联受体激酶5在散发性帕金森病发病机制中的作用
J Neurosci. 2006 Sep 6;26(36):9227-38. doi: 10.1523/JNEUROSCI.0341-06.2006.
6
Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.截短型人α-突触核蛋白(1-120)转基因小鼠黑质和嗅球中多巴胺能神经细胞的病理变化:对路易体疾病的影响
J Neurosci. 2006 Apr 12;26(15):3942-50. doi: 10.1523/JNEUROSCI.4965-05.2006.
7
Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease.非甾体抗炎药与帕金森病风险
Mov Disord. 2006 Jul;21(7):964-9. doi: 10.1002/mds.20856.
8
Genetics of Parkinson disease: paradigm shifts and future prospects.帕金森病的遗传学:范式转变与未来展望。
Nat Rev Genet. 2006 Apr;7(4):306-18. doi: 10.1038/nrg1831.
9
Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.热休克蛋白90与泛素在α-突触核蛋白病丝状α-突触核蛋白包涵体中的汇聚。
Am J Pathol. 2006 Mar;168(3):947-61. doi: 10.2353/ajpath.2006.050770.
10
Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally.向产前暴露于脂多糖(LPS)的大鼠脑黑质以上区域注入LPS后,多巴胺神经元进行性丧失。
Exp Neurol. 2006 Jun;199(2):499-512. doi: 10.1016/j.expneurol.2006.01.010. Epub 2006 Feb 28.

神经炎症以及与多巴胺能神经变性相关的α-突触核蛋白的氧化/硝化作用。

Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.

作者信息

Gao Hui-Ming, Kotzbauer Paul T, Uryu Kunihiro, Leight Susan, Trojanowski John Q, Lee Virginia M-Y

机构信息

Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

出版信息

J Neurosci. 2008 Jul 23;28(30):7687-98. doi: 10.1523/JNEUROSCI.0143-07.2008.

DOI:10.1523/JNEUROSCI.0143-07.2008
PMID:18650345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2702093/
Abstract

alpha-Synuclein (SYN) is the major component of Lewy bodies, the neuropathological hallmarks of Parkinson's disease (PD). Missense mutations and multiplications of the SYN gene cause autosomal dominant inherited PD. Thus, SYN is implicated in the pathogenesis of PD. However, the mechanism whereby SYN promotes neurodegeneration remains unclear. Familial PD with SYN gene mutations are rare because the majority of PD is sporadic and emerging evidence indicates that sporadic PD may result from genetic and environmental risk factors including neuroinflammation. Hence, we examined the relationship between SYN dysfunction and neuroinflammation in mediating dopaminergic neurodegeneration in mice and dopaminergic neuronal cultures derived from wild-type SYN and mutant A53T SYN transgenic mice in a murine SYN-null (SYNKO) background (M7KO and M83KO, respectively). Stereotaxic injection of an inflammagen, lipopolysaccharide, into substantia nigra of these SYN genetically engineered mice induced similar inflammatory reactions. In M7KO and M83KO, but not in SYNKO mice, the neuroinflammation was associated with dopaminergic neuronal death and the accumulation of insoluble aggregated SYN as cytoplasmic inclusions in nigral neurons. Nitrated/oxidized SYN was detected in these inclusions and abatement of microglia-derived nitric oxide and superoxide provided significant neuroprotection in neuron-glia cultures from M7KO mice. These data suggest that nitric oxide and superoxide released by activated microglia may be mediators that link inflammation and abnormal SYN in mechanisms of PD neurodegeneration. This study advances understanding of the role of neuroinflammation and abnormal SYN in the pathogenesis of PD and opens new avenues for the discovery of more effective therapies for PD.

摘要

α-突触核蛋白(SYN)是路易小体的主要成分,路易小体是帕金森病(PD)的神经病理学标志。SYN基因的错义突变和倍增会导致常染色体显性遗传型PD。因此,SYN与PD的发病机制有关。然而,SYN促进神经退行性变的机制仍不清楚。具有SYN基因突变的家族性PD很罕见,因为大多数PD是散发性的,而且新出现的证据表明散发性PD可能由包括神经炎症在内的遗传和环境风险因素引起。因此,我们研究了在小鼠以及源自野生型SYN和突变型A53T SYN转基因小鼠(分别为M7KO和M83KO)且背景为SYN基因敲除(SYNKO)的多巴胺能神经元培养物中,SYN功能障碍与神经炎症在介导多巴胺能神经退行性变中的关系。向这些经基因工程改造的SYN小鼠的黑质立体定向注射炎症原脂多糖会引发类似的炎症反应。在M7KO和M83KO小鼠中,但在SYNKO小鼠中未出现这种情况,神经炎症与多巴胺能神经元死亡以及不可溶性聚集SYN作为黑质神经元中的细胞质内含物的积累有关。在这些内含物中检测到了硝化/氧化的SYN,减少小胶质细胞衍生的一氧化氮和超氧化物在来自M7KO小鼠的神经元-胶质细胞培养物中提供了显著的神经保护作用。这些数据表明,活化的小胶质细胞释放的一氧化氮和超氧化物可能是在PD神经退行性变机制中连接炎症和异常SYN的介质。这项研究增进了对神经炎症和异常SYN在PD发病机制中作用的理解,并为发现更有效的PD治疗方法开辟了新途径。